Literature DB >> 22450427

High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis.

Peter Würtz1, Juho R Raiko, Costan G Magnussen, Pasi Soininen, Antti J Kangas, Tuulia Tynkkynen, Russell Thomson, Reino Laatikainen, Markku J Savolainen, Jari Laurikka, Pekka Kuukasjärvi, Matti Tarkka, Pekka J Karhunen, Antti Jula, Jorma S Viikari, Mika Kähönen, Terho Lehtimäki, Markus Juonala, Mika Ala-Korpela, Olli T Raitakari.   

Abstract

AIMS: High-throughput metabolite quantification holds promise for cardiovascular risk assessment. Here, we evaluated whether metabolite quantification by nuclear magnetic resonance (NMR) improves prediction of subclinical atherosclerosis in comparison to conventional lipid testing. METHODS AND
RESULTS: Circulating lipids, lipoprotein subclasses, and small molecules were assayed by NMR for 1595 individuals aged 24-39 years from the population-based Cardiovascular Risk in Young Finns Study. Carotid intima-media thickness (IMT), a marker of subclinical atherosclerosis, was measured in 2001 and 2007. Baseline conventional risk factors and systemic metabolites were used to predict 6-year incidence of high IMT (≥ 90 th percentile) or plaque. The best prediction of high intima-media thickness was achieved when total and HDL cholesterol were replaced by NMR-determined LDL cholesterol and medium HDL, docosahexaenoic acid, and tyrosine in prediction models with risk factors from the Framingham risk score. The extended prediction model improved risk stratification beyond established risk factors alone; area under the receiver operating characteristic curve 0.764 vs. 0.737, P =0.02, and net reclassification index 17.6%, P =0.0008. Higher docosahexaenoic acid levels were associated with decreased risk for incident high IMT (odds ratio: 0.74; 95% confidence interval: 0.67-0.98; P = 0.007). Tyrosine (1.33; 1.10-1.60; P = 0.003) and glutamine (1.38; 1.13-1.68; P = 0.001) levels were associated with 6-year incident high IMT independent of lipid measures. Furthermore, these amino acids were cross-sectionally associated with carotid IMT and the presence of angiographically ascertained coronary artery disease in independent populations.
CONCLUSION: High-throughput metabolite quantification, with new systemic biomarkers, improved risk stratification for subclinical atherosclerosis in comparison to conventional lipids and could potentially be useful for early cardiovascular risk assessment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22450427     DOI: 10.1093/eurheartj/ehs020

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  44 in total

Review 1.  Importance of receptor-targeted systems in the battle against atherosclerosis.

Authors:  Elisabet Rosas; Igor Sobenin; Alexander Orekhov; Elazer R Edelman; Mercedes Balcells
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

2.  Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy.

Authors:  Roger Mallol; Núria Amigó; Miguel A Rodríguez; Mercedes Heras; Maria Vinaixa; Núria Plana; Edmond Rock; Josep Ribalta; Oscar Yanes; Lluís Masana; Xavier Correig
Journal:  J Lipid Res       Date:  2015-01-07       Impact factor: 5.922

3.  Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.

Authors:  Cavin K Ward-Caviness; Tao Xu; Thor Aspelund; Barbara Thorand; Corinna Montrone; Christa Meisinger; Irmtraud Dunger-Kaltenbach; Astrid Zierer; Zhonghao Yu; Inga R Helgadottir; Tamara B Harris; Lenore J Launer; Andrea Ganna; Lars Lind; Gudny Eiriksdottir; Melanie Waldenberger; Cornelia Prehn; Karsten Suhre; Thomas Illig; Jerzy Adamski; Andreas Ruepp; Wolfgang Koenig; Vilmundur Gudnason; Valur Emilsson; Rui Wang-Sattler; Annette Peters
Journal:  Heart       Date:  2017-03-02       Impact factor: 5.994

4.  Sex and puberty-related differences in metabolomic profiles associated with adiposity measures in youth with obesity.

Authors:  Christoph Saner; Brooke E Harcourt; Ahwan Pandey; Susan Ellul; Zoe McCallum; Kung-Ting Kao; Celia Twindyakirana; Anke Pons; Erin J Alexander; Richard Saffery; David P Burgner; Markus Juonala; Matthew A Sabin
Journal:  Metabolomics       Date:  2019-05-03       Impact factor: 4.290

5.  Associations of serum LDL particle concentration with carotid intima-media thickness and coronary artery calcification.

Authors:  Maryam Zaid; Katsuyuki Miura; Akira Fujiyoshi; Robert D Abbott; Takashi Hisamatsu; Aya Kadota; Hisatomi Arima; Sayaka Kadowaki; Sayuki Torii; Naoko Miyagawa; Sentaro Suzuki; Naoyuki Takashima; Takayoshi Ohkubo; Akira Sekikawa; Hiroshi Maegawa; Minoru Horie; Yasuyuki Nakamura; Tomonori Okamura; Hirotsugu Ueshima
Journal:  J Clin Lipidol       Date:  2016-01-06       Impact factor: 4.766

6.  Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.

Authors:  Ville T Männistö; Marko Simonen; Pasi Soininen; Mika Tiainen; Antti J Kangas; Dorota Kaminska; Sari Venesmaa; Pirjo Käkelä; Vesa Kärjä; Helena Gylling; Mika Ala-Korpela; Jussi Pihlajamäki
Journal:  J Lipid Res       Date:  2014-10-24       Impact factor: 5.922

7.  Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.

Authors:  Peter Würtz; Aki S Havulinna; Pasi Soininen; Tuulia Tynkkynen; David Prieto-Merino; Therese Tillin; Anahita Ghorbani; Anna Artati; Qin Wang; Mika Tiainen; Antti J Kangas; Johannes Kettunen; Jari Kaikkonen; Vera Mikkilä; Antti Jula; Mika Kähönen; Terho Lehtimäki; Debbie A Lawlor; Tom R Gaunt; Alun D Hughes; Naveed Sattar; Thomas Illig; Jerzy Adamski; Thomas J Wang; Markus Perola; Samuli Ripatti; Ramachandran S Vasan; Olli T Raitakari; Robert E Gerszten; Juan-Pablo Casas; Nish Chaturvedi; Mika Ala-Korpela; Veikko Salomaa
Journal:  Circulation       Date:  2015-01-08       Impact factor: 29.690

8.  Association between serum fatty acids and lipoprotein subclass profile in healthy young adults: exploring common genetic and environmental factors.

Authors:  Aline Jelenkovic; Leonie H Bogl; Richard J Rose; Antti J Kangas; Pasi Soininen; Mika Ala-Korpela; Jaakko Kaprio; Karri Silventoinen
Journal:  Atherosclerosis       Date:  2014-01-21       Impact factor: 5.162

9.  Metabolic profiles of socio-economic position: a multi-cohort analysis.

Authors:  Oliver Robinson; Alice R Carter; Mika Ala-Korpela; Juan P Casas; Nishi Chaturvedi; Jorgen Engmann; Laura D Howe; Alun D Hughes; Marjo-Riitta Järvelin; Mika Kähönen; Ville Karhunen; Diana Kuh; Tina Shah; Yoav Ben-Shlomo; Reecha Sofat; Chung-Ho E Lau; Terho Lehtimäki; Usha Menon; Olli Raitakari; Andy Ryan; Rui Providencia; Stephanie Smith; Julie Taylor; Therese Tillin; Jorma Viikari; Andrew Wong; Aroon D Hingorani; Mika Kivimäki; Paolo Vineis
Journal:  Int J Epidemiol       Date:  2021-07-09       Impact factor: 7.196

10.  Treatment Adherence as Predictor of Outcome in Concentrated Exposure Treatment for Obsessive-Compulsive Disorder.

Authors:  Kristian Tjelle; Håvard Berg Opstad; Stian Solem; Gunvor Launes; Bjarne Hansen; Gerd Kvale; Kristen Hagen
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.